Literature DB >> 7254945

Heparin clearance in the newborn.

M M McDonald, L J Jacobson, W W Hay, W E Hathaway.   

Abstract

Twenty-five preterm newborns were given bolus infusions of sodium heparin (100 units/kg) and plasma heparin levels were assayed at 5, 20, 40, 90, and 150 min. Eight normal adults received a 75 units/kg bolus of heparin and levels were assayed at 5, 30, 60, 120, 180, and 240 min. In comparison with the adult data (mean adult plasma heparin half life (T1/2) = 63.3 min), the newborn infants demonstrated a significantly shorter plasma heparin half life (T1/2 = 35.5 min in group I, 33 to 36 wk gestation; 35.5 min in group II, 29 to 32 wk gestation; and 41.6 min in group III, 25 to 28 wk gestation), as demonstrated by a chromogenic heparin assay. The newborn groups, had a larger volume of distribution (Vd) of heparin which varied inversely with gestational age (Vd =36.6 ml/kg in the adults, 57.8 ml/kg in group I, 73.3 ml/kg in group II, and 81.0 ml/kg in group III babies. Heparin clearance (CI) was significantly greater in all newborn groups when compared with the adult (CIadult = 0.43 ml/kg/min; ClGrIII = 1.49 ml/kg/min). A one-stage clotting assay for heparin generated similar results, although infant plasma heparin levels were slightly higher by this assay. Before heparin administration, the mean antithrombin III antigen (AT-III Ag) of the babies was 26.5% of normal adult and was not furthur decreased 90 min after the heparin bolus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7254945     DOI: 10.1203/00006450-198107000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  21 in total

Review 1.  How We Manage Pediatric Deep Venous Thrombosis.

Authors:  Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

2.  Anticoagulation therapy advisor: a decision-support system for heparin therapy during ECMO.

Authors:  R L Peverini; M Sale; W D Rhine; L M Fagan; L A Lenert
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1992

Review 3.  How I treat venous thrombosis in children.

Authors:  Marilyn J Manco-Johnson
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

4.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 5.  Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.

Authors:  Cristina Tarango; Sam Schulman; Marisol Betensky; Neil A Goldenberg
Journal:  Expert Rev Hematol       Date:  2017-12-17       Impact factor: 2.929

6.  An evidence-based standardized protocol for anticoagulation following congenital heart surgery.

Authors:  Catherine Deshaies; Nancy Poirier; Paul Khairy
Journal:  Transl Pediatr       Date:  2018-10

Review 7.  Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.

Authors:  Colleen E Gruenwald; Cedric Manlhiot; Lynn Crawford-Lean; Celeste Foreman; Leonardo R Brandão; Brian W McCrindle; Helen Holtby; Ross Richards; Helen Moriarty; Glen Van Arsdell; Anthony K Chan
Journal:  J Extra Corpor Technol       Date:  2010-03

Review 8.  Congenital heart disease: current indications for antithrombotic therapy in pediatric patients.

Authors:  M D Reller
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

9.  Neonatal arterial iliac thrombosis in type-I protein C deficiency: a case report.

Authors:  Elisabetta Tridapalli; Marcello Stella; Maria G Capretti; Giacomo Faldella
Journal:  Ital J Pediatr       Date:  2010-03-08       Impact factor: 2.638

10.  Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients.

Authors:  Hesham Al-Sallami; Fiona Newall; Paul Monagle; Vera Ignjatovic; Noel Cranswick; Stephen Duffull
Journal:  Br J Clin Pharmacol       Date:  2016-05-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.